Growth of newly diagnosed, untreated metastatic gastrinomas and predictors of growth patterns

Journal of Clinical Oncology

Volumn 15, Issue 6, 1997, Pages 2420-2431

  Sutliff, Vincent E ^a   Doppman, John L ^a   Gibril, Fathia ^a   Venzon, David J ^a   Yu, Fang ^a   Serrano, Jose ^a   Jensen, Robert T ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GASTRIN;

ADULT; AGED; ARTICLE; BONE METASTASIS; CANCER GROWTH; CANCER MORTALITY; CLINICAL ARTICLE; FEMALE; FOLLOW UP; GASTRIN BLOOD LEVEL; GASTRINOMA; HUMAN; LIVER METASTASIS; MALE; PANCREAS CANCER; PRIORITY JOURNAL; ZOLLINGER ELLISON SYNDROME;

EID: 0030940737     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1997.15.6.2420     Document Type: Article

References (67)

1. Norton JA: Neuroendocrine tumors of the pancreas and duodenum. Curr Probl Surg 31:1-156, 1994
2. Mignon M, Jensen RT (eds): Endocrine Tumors of the Pancreas: Recent Advances in Research and Management. Series: Frontiers of Gastrointestinal Research. Basel, Switzerland. Karger, 1995
3. Fraker DL, Jensen RT: Pancreatic endocrine tumors, in DeVita VT, Hellman S, Rosenberg SA (eds): Cancer: Principles and Practice of Oncology (ed 3). Philadelphia, PA, Lippincott-Raven, 1997, pp 1678-1704
4. Creutzfeldt W: Insulinomas: Clinical presentation, diagnosis, and advances in management, in Mignon M, Jensen RT (eds): Endocrine Tumors of the Pancreas: Recent Advances in Research and Management. Series: Frontiers of Gastrointestinal Research. Basel, Switzerland, Karger, 1995, pp 148-165
5. Ellison EH, Wilson SD: The Zollinger-Ellison syndrome: Reappraisal and evaluation of 260 registered cases. Ann Surg 160:512-530, 1964
6. Jensen RT, Gardner JD: Gastrinoma, in Go VLW, DiMagno EP, Gardner JD, et al (eds): The Pancreas: Biology, Pathobiology and Disease (ed 2). New York, NY, Raven, 1993, pp 931-978
7. Metz DC, Jensen RT: Advances in gastric antisecretory therapy in Zollinger-Ellison syndrome, in Mignon M, Jensen RT (eds): Endocrine Tumors of the Pancreas: Recent Advances in Research and Management. Series: Frontiers of Gastrointestinal Research. Basel, Switzerland, Karger, 1995, pp 240-257
8. Scarpignato C: Somatostatin analogues in the management of endocrine tumors of the pancreas, in Mignon M, Jensen RT (eds): Endocrine Tumors of the Pancreas: Recent Advances in Research and Management. Series: Frontiers in Gastrointestinal Research. Basel, Switzerland, Karger, 1995, pp 385-414
9. Norton JA, Levin B, Jensen RT: Cancer of the endocrine system, in DeVita VT Jr, Hellman S, Rosenberg SA (eds): Cancer: Principles and Practice of Oncology (ed 4). Philadelphia, PA, Lippincott, 1993, pp 1333-1435
10. Weber HC, Venzon DJ, Lin JT, et al: Determinants of metastatic rate and survival in patients with Zollinger-Ellison syndrome: A prospective long-term study. Gastroenterology 108:1637-1649, 1995
11. Zollinger RM, Martin EW Jr, Carey LC, et al: Observations on the postoperative tumor growth behavior of certain islet cell tumors. Ann Surg 184:525-530, 1976
12. Fox PS, Hofmann JW, Wilson SD, et al: Surgical management of the Zollinger-Ellison syndrome. Surg Clin North Am 54:395-407, 1974
13. Matuchansky C, Rambaud JC: VIPomas and endocrine cholera: Clinical presentation, diagnosis, and advances in management, in Mignon M, Jensen RT (eds): Endocrine Tumors of the Pancreas: Recent Advances in Research and Management. Series: Frontiers of Gastrointestinal Research. Basel, Switzerland, Karger, 1995, pp 166-182
14. Jensen RT: Pancreatic endocrine tumors. Recent advances, in Sleisenger MH, Fordtran JS (eds): Gastrointestinal Disease. Pathophysiology, Diagnosis and Management (ed 5). Philadelphia, PA, Saunders, 1995, pp 1-17
15. Mignon M, Jais P, Cadiot G, et al: Clinical features and advances in biological diagnostic criteria for Zollinger-Ellison syndrome, in Mignon M, Jensen RT (eds): Endocrine Tumors of the Pancreas: Recent Advances in Research and Management. Series: Frontiers of Gastrointestinal Research. Basel, Switzerland, Karger, 1995, pp 223-239
16. Guillausseau PJ, Guillausseau-Scholer C: Glucagonomas: Clinical presentation, diagnosis, and advances in management, in Mignon M, Jensen RT (eds): Endocrine Tumors of the Pancreas: Recent Advances in Research and Management. Series: Frontiers of Gastrointestinal Research. Basel, Switzerland, Karger, 1995, pp 183-193
17. Sassolas G, Chayvialle JA: GRFomas, somatostatinomas: Clinical presentation, diagnosis, and advances in management, in Mignon M, Jensen RT (eds): Endocrine Tumors of the Pancreas: Recent Advances in Research and Management. Series: Frontiers of Gastrointestinal Research. Basel, Switzerland, Karger, 1995, pp 194-207
18. Eriksson B, Oberg K: PPomas and nonfunctioning endocrine pancreatic tumors: Clinical presentation, diagnosis, and advances in management, in Mignon M, Jensen RT (eds): Endocrine Tumors of the Pancreas: Recent Advances in Research and Management. Series: Frontiers of Gastrointestinal Research. Basel, Switzerland, Karger, 1995, pp 208-222
19. Doppman JL, Nieman L, Miller DL, et al: Ectopic adrenocorticotropic hormone syndrome: Localization studies in 28 patients. Radiology 172:115-124, 1989 (erratum, 173:286, 1989)
20. Jensen RT, Norton JA: Endocrine tumors of the pancreas, in Yamada T, Alpers BH, Owyang C, et al (eds): Textbook of Gastroenterology (ed 2). Philadelphia, PA, Lippincott, 1995, pp 2131-2166
21. Doppman JL, Nieman LK, Cutler GB Jr, et al: Adrenocorticotropic hormone-secreting islet cell tumors: Are they always malignant? Radiology 190:59-64, 1994
22. Grama D, Eriksson B, Martensson H, et al: Clinical characteristics, treatment and survival in patients with pancreatic tumors causing hormonal syndromes. World J Surg 16:632-639, 1992
23. Stabile BE, Passaro E Jr: Benign and malignant gastrinoma. Am J Surg 49:144-150, 1985
24. Oberg K: The use of chemotherapy in the management of neuroendocrine tumors. Endocrinol Metab Clin North Am 22:941-952, 1993
25. Arnold R, Frank M: Systemic chemotherapy for endocrine tumors of the pancreas: recent advances, in Mignon M, Jensen RT (eds): Endocrine Tumors of the Pancreas: Recent Advances in Research and Management. Series: Frontiers of Gastrointestinal Research. Basel, Switzerland, Karger, 1995, pp 431-438
26. von Schrenck T, Howard JM, Doppman JL, et al: Prospective study of chemotherapy in patients with metastatic gastrinoma. Gastroenterology 94:1326-1334, 1988
27. Moertel CG, Lefkopoulo M, Lipsitz S, et al: Streptozotocindoxorubicin, streptozotocin-flourouracil or chlorozotocin in the treatment of advanced islet cell carcinoma. N Engl J Med 326:519-523, 1992
28. Ruszniewski P, Hochlaf S, Rougier P, et al: Intravenous chemotherapy with streptozotocin and 5-fluorouracil for hepatic metastases of Zollinger-Ellison syndrome. A prospective multicenter study in 21 patients. Gastroenterol Clin Biol 15:393-398, 1991
29. Eriksson B, Oberg K: Interferon therapy of malignant endocrine pancreatic tumors, in Mignon M, Jensen RT (eds): Endocrine Tumors of the Pancreas: Recent Advances in Research and Management. Series: Frontiers of Gastrointestinal Research. Basel, Switzerland, Karger, 1995, pp 451-460
30. Arnold R, Trautmann ME, Creutzfeldt W, et al: Somatostatin analogue octreotide and inhibition of tumour growth in metastatic endocrine gastroenteropancreatic tumours. Gut 38:430-438, 1996
31. Ruszniewski P, Rougier P, Roche A, et al: Hepatic arterial chemoembolization in patients with liver metastases of endocrine tumors. A prospective phase II study in 24 patients. Cancer 71:2624-2630, 1993
32. Norton JA: Advances in the management of Zollinger-Ellison syndrome. Adv Surg 27:129-159, 1994
33. Nagorney DM, Que FG: Cytoreductive hepatic surgery for metastatic gastrointestinal neuroendocrine tumors, in Mignon M, Jensen RT (eds): Endocrine Tumors of the Pancreas: Recent Advances in Research and Management. Series: Frontiers of Gastrointestinal Research. Basel, Switzerland, Karger, 1995, pp 416-430
34. Carty SE, Jensen RT, Norton JA: Prospective study of aggressive resection of metastatic pancreatic endocrine tumors. Surgery 112:1024-1031, 1992
35. Jensen RT: Pancreatic endocrine tumors. Curr Opin Gastroenterol 11:423-429, 1995
36. Azoulay D, Bismuth H: Role of liver surgery and transplantation in patients with hepatic metastases from pancreatic endocrine tumors, in Mignon M, Jensen RT (eds): Endocrine Tumors of the Pancreas: Recent Advances in Research and Management. Series: Frontiers of Gastrointestinal Research. Basel, Switzerland, Karger, 1995, pp 461-476
37. Fishbeyn VA, Norton JA, Benya RV, et al: Assessment and prediction of long-term cure in patients with Zollinger-Ellison syndrome: The best approach. Ann Intern Med 119:199-206, 1993
38. Metz DC, Pisegna JR, Fishbeyn VA, et al: Control of gastric acid hypersecretion in the management of patients with Zollinger-Ellison syndrome. World J Surg 17:468-480, 1993
39. Frucht H, Howard JM, Slaff JI, et al: Secretin and calcium provocative tests in the Zollinger-Ellison syndrome: A prospective study. Ann Intern Med 111:713-722, 1989
40. Orbuch M, Doppman JL, Strader DB, et al: Imaging for pancreatic endocrine tumor localization: recent advances, in Mignon M, Jensen RT (eds): Endocrine Tumors of the Pancreas: Recent Advances in Research and Management. Frontiers of Gastrointestinal Research. Basel, Switzerland, Karger, 1995, pp 268-281
41. Jensen RT: Gastrin-producing tumors. Cancer Treat Res (in press)
42. Benya RV, Metz DC, Venzon DJ, et al: Zollinger-Ellison syndrome can be the initial endocrine manifestation in patients with multiple endocrine neoplasia-type 1. Am J Med 97:436-444, 1994
43. Pisegna JR, Slimak GG, Doppman JL, et al: An evaluation of human recombinant alpha interferon in patients with metastatic gastrinoma. Gastroenterology 105:1179-1183, 1993
44. Norton JA, Sugarbaker PH, Doppman JL, et al: Aggressive resection of metastatic disease in selected patients with malignant gastrinoma. Ann Surg 203:352-359, 1986
45. Wank SA, Doppman JL, Miller DL, et al: Prospective study of the ability of computerized axial tomography to localize gastrinomas in patients with Zollinger-Ellison syndrome. Gastroenterology 92:905-912, 1987
46. Gibril F, Reynolds JC, Doppman JL, et al: Somatostatin receptor scintigraphy: Its sensitivity compared with that of other imaging methods in detecting primary and metastatic gastrinomas: A prospective study. Ann Intern Med 125:26-34, 1996
47. Termanini B, Gibril F, Doppman JL, et al: Somatostatin receptor scintigraphy, a new agent to distinguish small hepatic hemangiomas from vascular liver metastases in patients with gastrinomas. Radiology 202:151-158, 1997
48. Pisegna JR, Doppman JL, Norton JA, et al: Prospective comparative study of ability of MR imaging and other imaging modalities to localize tumors in patients with Zollinger-Ellison syndrome. Dig Dis Sci 38:1318-1328, 1993
49. Jensen RT, Doppman JL, Gardner JD: Gastrinoma, in Go VLW, Brooks FA, DiMagno EP, et al (eds): The Exocrine Pancreas: Biology, Pathobiology and Disease. New York, NY, Raven, 1986, pp 727-744
50. Mignon M, Ruszniewski P, Haffar S, et al: Current approach to the management of tumoral process in patients with gastrinoma. World J Surg 10:703-710, 1986
51. Oberg K, Eriksson B, Janson ET: The clinical use of interferons in the management of neuroendocrine gastroenteropancreatic tumors. Ann NY Acad Sci 733:471-478, 1994
52. Jensen RT, Norton JA: Carcinoid tumors and the carcinoid syndrome, in DeVita VT Jr, Hellman S, Rosenberg SA (eds): Cancer: Principles and Practice of Oncology. Philadelphia, PA, Lippincott-Raven, 1997, pp 1704-1723
53. Miller LS, Doppman J, Maton PN, et al: Zollinger-Ellison syndrome. Advances in diagnosis and treatment. Handbook Exp Pharmacol 99:349-400, 1991
54. Ishak KG, Rabin L: Benign tumors of the liver. Med Clin North Am 59:995-1013, 1975
55. Moriura S, Ikeda S, Hirai M, et al: Hepatic gastrinoma. Cancer 72:1547-1550, 1993
56. Malagelada J, Edis AJ, Adson MA, et al: Medical and surgical options in the management of patients with gastrinoma. Gastroenterology 84:1524-1532, 1983
57. Eriksson B, Oberg K, Skogseid B: Neuroendocrine pancreatic endocrine tumors. Clinical findings in a prospective study of 84 patients. Acta Oncol 28:373-377, 1989
58. Ruszniewski P, Podevin P, Cadiot G, et al: Clinical, anatomical, and evolutive features of patients with the Zollinger-Ellison syndrome combined with type I multiple endocrine neoplasia. Pancreas 8:295-304, 1993
59. Moertel CG, Johnson CM, McKusick MA, et al: The management of patients with advanced carcinoid tumors and islet cell carcinomas. Ann Intern Med 120:302-309, 1994
60. Moertel CG, Hanley JA, Johnson LA: Streptozotocin alone compared with streptozotocin plus fluorouracil in the treatment of advanced islet-cell carcinoma. N Engl J Med 303:1189-1194, 1980
61. Moertel CG, Kvols LK, O'Connell MJ, et al: Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin. Evidence of major therapeutic activity in the anaplastic variants of these neoplasms. Cancer 68:227-232, 1991
62. Eriksson B: Tumor markers for pancreatic endocrine tumors, including chromogranins, HCG-alpha and HCG-beta, in Mignon M, Jensen RT (eds): Endocrine Tumors of the Pancreas: Recent Advances in Research and Management. Series: Frontiers of Gastrointestinal Research. Basel, Switzerland, Karger, 1995, pp 121-131
63. Stridsberg M, Oberg K, Li Q, et al: Measurements of chromogranin A, chromogranin B (secretogranin I), chromogranin C (secretogranin II) and pancreastatin in plasma and urine from patients with carcinoid tumours and endocrine pancreatic tumours. J Endocrinol 144:49-59, 1995
64. Termanini B, Gibril F, Reynolds JC, et al: Value of somatostatin receptor scintigraphy: A prospective study in Zollinger-Ellison syndrome of its effect on clinical management. Gastroenterology 122:335-347, 1997
65. Krenning EP, Kwekkeboom DJ, Oei HY, et al: Somatostatin-receptor scintigraphy in gastroenteropancreatic tumors. Ann NY Acad Sci 733:416-424, 1994
66. de Kerviler E, Cadiot G, Lebtahi R, et al: Somatostatin receptor scintigraphy in forty-eight patients with the Zollinger-Ellison syndrome. Eur J Nucl Med 21:1191-1197, 1994
67. Gibril F, Termanini B, Stewart CA, et al: Prospective study of the occurrence of metastases to bone in patients with Zollinger-Ellison syndrome (ZES). Gastroenterology 110:A1073, 1996 (abstr)